B+
Bull case
30%
Probability
Target price
$225.00
+65.9% vs current
WMS
Advanced DrainageCNYSE / Capital Goods
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$190.00
+40.1% vs current
B-
Bear case
20%
Probability
Target price
$110.00
-18.9% vs current
AI sentiment snapshot
Latest data as of 2026-05-24
Recent news sentiment (30D)
+0.6
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+85.4
Score
AI commentary
Post-print coverage was mixed: the company beat on adjusted EPS and lifted FY2027 sales/EBITDA targets, but management's cautious demand framing weighed on sentiment and secondary coverage described an initially negative share reaction. Analyst revision data were limited in the packet, and the repaired peer set remains only partially direct, so the report should be treated as constructive monitoring rather than a clean bullish re-rating.
RankAlpha Sentiment Codex - 2026-05-24
Open post-earnings memoEvidence flagged
peer set is too generic or lacks enough direct operating comparators
Impact
tentative
Confidence
-
AI events
2026-05-21eventFY2026 print beat and FY2027 guideMedium impact
ADS reported Q4 net sales of $676.8M (+9.9%), adjusted EPS of $1.07 (+3.9%), and FY2027 guidance for $3.35B-$3.55B of sales and $1.0B-$1.05B of adjusted EBITDA, while explicitly flagging a cautious demand backdrop; the release tied upside to NDS and Allied product contribution. [#8-K-2026-05-21]
2026-08-31catalystFY2027 demand caution could cap reratingMedium impact
Management explicitly called FY2027 demand cautious because of geopolitical uncertainty, elevated interest rates, slower residential construction, and integration/transaction costs; if those pressures persist, the market may keep discounting ADS despite the beat. [#8-K-2026-05-21]
2027-03-31catalystNDS mix shift and cash return capacityHigh impact
The closed NDS acquisition broadened scale and the company said higher-margin Infiltrator and Allied products rose 14% and 13% in FY2026, represented 48% of revenue, and helped support a 31.6% adjusted EBITDA margin; operating cash flow was $819.1M and year-end share-repurchase authorization still had $1.0B remaining. [#10-K-2026-05-21]
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-24 • Updated nightlySource: Internal modelMethodology